V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10447211 | 10033956 | 1.8 | 80 | Adjuvant (A) | 2018-01-12 | 2018-01-14 | Rituximab | Y | N | RITUXIMAB | 101766132 |
| 10447230 | 10033957 | 1.7 | 72.9 | null | 2021-12-09 | 2021-12-24 | Rituximab | 02 | null | PEMBROLIZUMAB | 101037296 |
| 10447267 | 10033958 | 1.77 | 70.9 | 03 | 2021-02-24 | 2021-02-24 | Rituximab | 02 | null | RITUXIMAB | 101288188 |
| 10447289 | 10033959 | null | 75 | null | 2022-04-07 | 2022-04-11 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101405760 |
| 10447317 | 10033960 | 1.63 | null | Palliative (P) | 2017-08-27 | 2017-09-04 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 101040007 |
| 10447325 | 10033961 | 1.67 | 46 | 03 | 2020-01-29 | 2020-02-20 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 101391153 |
| 10447335 | 10033962 | 1.8 | 64.9 | 03 | 2020-01-04 | 2020-01-19 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 101819107 |
| 10447339 | 10033963 | 1.8 | 56.8 | Palliative (P) | 2016-02-28 | 2016-03-17 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101264880 |
| 10447379 | 10033964 | null | 72.5 | Palliative (P) | 2019-06-01 | 2019-09-03 | Rituximab | 02 | N | RITUXIMAB | 100194556 |
| 10447395 | 10033965 | 1.55 | 76.2 | null | null | 2020-11-03 | Docetaxel | 02 | null | DOCETAXEL | 101450580 |
| 10447429 | 10033966 | 1.7 | 95 | null | null | 2021-08-10 | Capecitabine 35days + RT | 02 | null | CAPECITABINE | 100480660 |
| 10447440 | 10033967 | 1.77 | 0 | null | 2018-07-27 | 2018-08-13 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101604322 |
| 10447463 | 10033968 | 1.8 | 71 | Palliative (P) | 2018-12-18 | 2018-12-27 | Rituximab | 02 | N | RITUXIMAB | 100428320 |
| 10447478 | 10033969 | 1.75 | 55.6 | Palliative (P) | 2017-01-08 | 2017-01-22 | PEMBROLIZUMAB | 02 | N | IBRUTINIB | 100740227 |
| 10447546 | 10033970 | 1.8 | 76.5 | null | 2019-02-24 | 2019-02-25 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101588284 |
| 10447555 | 10033971 | 1.63 | 49.8 | null | 2016-11-20 | 2016-11-21 | Capecitabine + Oxaliplatin 21day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101034068 |
| 10447575 | 10033972 | 1.87 | 83.9 | Palliative (P) | 2015-05-18 | 2015-05-20 | IBRUTINIB | 02 | N | IBRUTINIB | 100371578 |
| 10447579 | 10033973 | null | 86.6 | null | 2017-03-05 | 2017-03-18 | Capecitabine + Oxaliplatin 21day | 02 | null | IBRUTINIB | 101429463 |
| 10447585 | 10033974 | 1.58 | 70 | Adjuvant (A) | 2016-09-29 | 2016-10-06 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 100421341 |
| 10447591 | 10033975 | 1.68 | 60.4 | Palliative (P) | 2018-05-30 | 2018-06-08 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 100675477 |
| 10447610 | 10033976 | 1.63 | 61.9 | 03 | 2017-02-21 | 2017-03-06 | Capecitabine | 99 | N | CAPECITABINE | 100207284 |
| 10447644 | 10033977 | 1.73 | 58 | Curative (C) | 2020-06-29 | 2020-07-15 | IBRUTINIB | N | N | IBRUTINIB | 100538059 |
| 10447654 | 10033978 | 1.71 | 74.8 | Palliative (P) | 2017-06-21 | 2017-06-23 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 100625359 |
| 10447738 | 10033979 | 1.57 | null | Palliative (P) | null | 2016-07-01 | IBRUTINIB | N | N | IBRUTINIB | 101000163 |
| 10447785 | 10033980 | 1.68 | 63.2 | 03 | 2019-03-17 | 2019-03-27 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100767763 |
| 10447786 | 10033981 | 1.8 | 75 | null | 2021-11-11 | 2021-11-29 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101172137 |
| 10447796 | 10033982 | 1.64 | 71.5 | Adjuvant (A) | null | 2017-02-25 | IBRUTINIB | N | N | IBRUTINIB | 101512481 |
| 10447824 | 10033983 | 1.59 | 88.2 | Adjuvant (A) | 2014-12-28 | 2015-01-18 | Rituximab | 02 | N | RITUXIMAB | 101510632 |
| 10447849 | 10033984 | 1.82 | 75.95 | Neo-adjuvant (N) | 2019-04-14 | 2019-05-07 | Rituximab | 02 | null | RITUXIMAB | 101436084 |
| 10447851 | 10033985 | 1.75 | 95.4 | Neo-adjuvant (N) | 2018-04-19 | 2018-04-19 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101042427 |
| 10447857 | 10033986 | 1.77 | 80.9 | 03 | 2021-06-01 | 2021-06-24 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 101733743 |
| 10447859 | 10033987 | 1.77 | 86 | Curative (C) | 2019-09-06 | 2019-09-07 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101075705 |
| 10447865 | 10033988 | 1.65 | 70 | Adjuvant (A) | 2017-08-05 | 2020-09-03 | IBRUTINIB | 02 | null | IBRUTINIB | 101326423 |
| 10447884 | 10033989 | 1.58 | 64 | Neo-adjuvant (N) | 2021-10-29 | 2021-10-29 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100419229 |
| 10447892 | 10033990 | 1.75 | 78.8 | Palliative (P) | 2019-10-30 | 2019-11-10 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101286405 |
| 10447896 | 10033991 | 1.79 | 64 | null | 2021-09-07 | 2021-09-09 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100348639 |
| 10447902 | 10033992 | 0 | 79.1 | Palliative (P) | 2018-05-14 | 2018-07-27 | IBRUTINIB | 02 | N | IBRUTINIB | 100426903 |
| 10447931 | 10033993 | 1.51 | 100.2 | Curative (C) | 2020-01-07 | 2020-01-27 | Rituximab | 02 | N | RITUXIMAB | 101243775 |
| 10447941 | 10033994 | 1.73 | 67.2 | null | 2020-04-29 | 2020-05-20 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100046866 |
| 10447954 | 10033995 | 1.7 | 59.8 | Adjuvant (A) | 2018-05-14 | 2018-05-28 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 100284034 |
| 10447967 | 10033996 | 1.5 | 60 | null | 2021-06-28 | 2021-07-14 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE | 100916720 |
| 10447975 | 10033997 | 1.65 | 84 | Disease modification (D) | 2018-08-17 | 2018-08-19 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101725454 |
| 10448028 | 10033998 | 1.7 | 81.1 | Adjuvant (A) | 2019-11-06 | 2019-11-07 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100458090 |
| 10448034 | 10033999 | 1.88 | 66.5 | Palliative (P) | 2020-02-01 | 2020-02-09 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 100144612 |
| 10448035 | 10034000 | 1.61 | 76.2 | Neo-adjuvant (N) | 2021-08-07 | 2021-08-07 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101185516 |
| 10448044 | 10034001 | 1.8 | 46 | Palliative (P) | 2019-09-14 | 2019-10-01 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100197443 |
| 10448048 | 10034002 | 1.72 | 81.3 | Palliative (P) | 2019-03-03 | 2019-03-23 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 100622606 |
| 10448071 | 10034003 | 1.71 | 60 | Neo-adjuvant (N) | 2020-12-19 | 2020-12-24 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100105307 |
| 10448075 | 10034004 | 1.56 | 78.5 | Disease modification (D) | 2013-02-27 | 2018-02-20 | Capecitabine | 02 | N | CAPECITABINE | 100445673 |
| 10448080 | 10034005 | 1.71 | 80 | null | 2022-03-15 | 2022-03-29 | IBRUTINIB | 02 | null | IBRUTINIB | 100992316 |